Aethlon Medical (AEMD) Return on Capital Employed (2011 - 2026)
Aethlon Medical's (AEMD) quarterly Return on Capital Employed came in at 126.88% in Q1 2026, up 5835.0% YoY from 2.14% in Q1 2025, and down 10.78% quarter-over-quarter from 114.54% in Q4 2025.
Aethlon Medical (AEMD) Return on Capital Employed (2011 - 2026) Analysis & Trends
Aethlon Medical's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 126.88% for Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 5835.0% year-over-year to 126.88%; the trailing twelve-month figure through Mar 2026 stood at 126.88% (up 5835.0% YoY), and the FY2026 full-year result was 135.08%, up 2315.0% from the prior year.
- Return on Capital Employed was 126.88% for Q1 2026 at Aethlon Medical, down from 114.54% in the prior quarter.
- Over the last five years, Return on Capital Employed for AEMD reached as high as 55.3% in Q1 2022 and fell as low as 185.23% in Q1 2025.
- Median Return on Capital Employed over the past 5 years was 126.88% (2026), compared with a mean of 119.4%.
- Across the five-year window, Return on Capital Employed slumped 10067 bps in 2024 and jumped 5835 bps in 2026, its largest moves.
- Over 5 years, Return on Capital Employed stood at 67.9% in 2022, then slumped by 95 bps to 132.49% in 2023, then retreated by 25 bps to 166.15% in 2024, then jumped by 31 bps to 114.54% in 2025, then decreased by 11 bps to 126.88% in 2026.
- Business Quant data shows AEMD's Return on Capital Employed at 126.88% in Q1 2026, 114.54% in Q4 2025, and 145.04% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Aethlon Medical | 3.70 Mn | -1.32 Mn | - | -126.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.88% |
| Dec 31, 2025 | -114.54% |
| Sep 30, 2025 | -145.04% |
| Jun 30, 2025 | -180.93% |
| Mar 31, 2025 | -185.23% |
| Dec 31, 2024 | -166.15% |
| Sep 30, 2024 | -148.41% |
| Jun 30, 2024 | -153.85% |
| Mar 31, 2024 | -168.23% |
| Dec 31, 2023 | -132.49% |
| Sep 30, 2023 | -94.50% |
| Jun 30, 2023 | -83.60% |
| Mar 31, 2023 | -67.56% |
| Dec 31, 2022 | -67.90% |
| Sep 30, 2022 | -71.63% |
| Jun 30, 2022 | -67.52% |
| Mar 31, 2022 | -55.30% |
| Dec 31, 2021 | -40.78% |
| Sep 30, 2021 | -36.89% |
| Jun 30, 2021 | -50.06% |